GDNF and Parkinson disease: These cells represent a promising therapeutic option for cell-based treatments in PD, capable of protecting nigral neurons and promoting the regeneration of dopaminergic pathways through the sustained release of GDNF (glial cell line-derived neurotrophic factor).